In this guest editorial discover what remains in our arsenal to combat antibiotic resistance, and how HORIBA Medical is advancing responsible prescribing to protect patient outcomes
In sepsis, the delay of even one hour in diagnosis can mean the difference between life and death. What if a standard blood test powered by AI, could flag the risk before symptoms even appear?
Yumizen H550 range expands to introduce new applications and configurable hematology options for small to mid-throughput laboratories
HORIBA Evolutive Laboratory Organisation (HELO) 2.0 embeds advanced hematology technologies to offer flexible, high-throughput, high-quality analytical performance
CellaVision integration with HORIBA’s HELO automated hematology platform enables unique two-way data flow and rapid results validation
Microsemi CRP hematology analyzers have been installed during COVID-19 ‘lockdown’ in POC locations to help reduce hospital admissions
The Yumizen G200 has been confirmed as suitable for blood coagulation external quality assessment testing
New Yumizen G coagulation analyzers and reagent range designed to suit any laboratory
